(Dr. Matthew Holman) - There is a piece of good public health news that deserves more attention: youth tobacco use in the United States has fallen to historically low levels. That progress did not happen by accident. It reflects years of prevention work, stronger age restrictions, public education, and a broad consensus that tobacco and nicotine products should not be used by anyone under the legal age.

(Peter Pitts, President and Co-founder of the Center for Medicine in the Public Interest ) - Consumers purchasing retatrutide online may think they are buying a safe, clinically tested weight-loss drug. They are not. Medical spas and online sellers have built a booming black market around an unapproved investigational drug – exploiting polished websites and professional packaging to sell illegal drugs to unsuspecting Americans. What is especially concerning about today’s version of this deception is how FDA is doing nothing to stop it, allowing this black market to turn into a digital-age Wild West. 

(NewsUSA) - It's no secret that kids today are struggling with mental health. Heightened academic pressure, the stress of growing up, family dynamics and lack of social connection all play a role, alongside the overuse of phones and devices. 

(Alliance for Safe Online Pharmacies) - Over the past few months, you may have come across advertisements online or on social media for a new weight loss drug called retatrutide, also commonly referred to as “Reta” or “GLP-3.” Despite savvy marketing and “personal testimonials,” there is something critical consumers need to know: retatrutide is not FDA approved for human-use, and the companies selling it are operating illegally through unregulated channels. 

You Can’t Verify What’s in Illicit Retatrutide – Or Where It Even Came From 

(Erika Braaksma ) - While World Lung Cancer Day was recognized on August 1, the urgent need to raise global awareness for those affected by the disease and to accelerate the search for a cure remains year-round. With this ongoing mission in mind, Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC) are observing the month by awarding $200,000 to two of the field's most promising young scientists. This investment addresses a critical reality in oncology: too often, brilliant research ideas stall not because they lack vision, but because they lack resources.